Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors

by Pal, Sumanta Kumar, Figlin, Robert A.
Published 2010

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

by Pal, Sumanta Kumar, Figlin, Robert A.
Published 2011

A Rare Finding of a BRAF Mutation in Renal Cell Carcinoma with Response to BRAF-Directed Targeted Therapy

by Banerjee, Natasha, Sachdev, Esha, Figlin, Robert A
Published in Cureus (2016)

Deciphering the anticancer mechanisms of sunitinib

by Pal, Sumanta Kumar, Figlin, Robert A, Yu, Hua
Published 2010

Targeted Therapies for Non-Small Lung Cancer: An Evolving Landscape

by Pal, Sumanta Kumar, Figlin, Robert A., Reckamp, Karen
Published 2010

A New Age for Vaccine Therapy in Renal Cell Carcinoma

by Pal, Sumanta K., Hu, Adriana, Figlin, Robert A.
Published 2013

Renal cell carcinoma: An update for the practicing urologist

by Pal, Sumanta K., Bergerot, Paulo, Figlin, Robert A.
Published in Asian J Urol (2015)

Gut microbiome, antibiotic use, and immunotherapy responsiveness in cancer

by Reed, Jarred P., Devkota, Suzanne, Figlin, Robert A.
Published in Ann Transl Med (2019)

Renal cell carcinoma molecular targets and clinical applications, second edition /

by Bukowski, Ronald M., Figlin, Robert A., Motzer, Robert J.
Published 2009

Renal cell carcinoma translational biology, personalized medicine, and novel therapeutic targets /

by Figlin, Robert A., Rathmell, W. Kimryn., Rini, Brian I.
Published 2012

Chemokines as therapeutic targets in renal cell carcinoma

by Reckamp, Karen L, Strieter, Robert M, Figlin, Robert A
Published 2008

Tivozanib: Current status and future directions in the treatment of solid tumors

by Pal, Sumanta K., Bergerot, Paulo G., Figlin, Robert A.
Published 2012

Surveillance Strategies for Renal Cell Carcinoma Patients Following Nephrectomy

by Chin, Arnold I, Lam, John S, Figlin, Robert A, Belldegrun, Arie S
Published 2006

Akt inhibitors in clinical development for the treatment of cancer

by Kumar Pal, Sumanta, Reckamp, Karen, Yu, Hua, Figlin, Robert A.
Published 2010

Breaking through a plateau in renal cell carcinoma therapeutics: Development and incorporation of biomarkers

by Pal, Sumanta Kumar, Kortylewski, Marcin, Yu, Hua, Figlin, Robert A.
Published 2010

Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma

by Motzer, Robert J., Escudier, Bernard, Gannon, Andrew, Figlin, Robert A.
Published in Oncologist (2016)

Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults

by Pal, Sumanta K., Vanderwalde, Ari, Hurria, Arti, Figlin, Robert A.
Published in Drugs Aging (2011)

STAT3: A Target to Enhance Antitumor Immune Response

by Lee, Heehyoung, Pal, Sumanta Kumar, Reckamp, Karen, Figlin, Robert A., Yu, Hua
Published 2011

A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models

by Zhang, Hao, Berel, Dror, Wang, Yanping, Li, Ping, Bhowmick, Neil A., Figlin, Robert A., Kim, Hyung L.
Published 2013

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

by Reckamp, Karen L, Figlin, Robert A, Burdick, Marie D, Dubinett, Steven M, Elashoff, Robert M, Strieter, Robert M
Published 2009